These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 3279489)
1. Specific toxicologic aspects of the quinolones. Christ W; Lehnert T; Ulbrich B Rev Infect Dis; 1988; 10 Suppl 1():S141-6. PubMed ID: 3279489 [TBL] [Abstract][Full Text] [Related]
2. Quinolone toxicity: methods of assessment. Patterson DR Am J Med; 1991 Dec; 91(6A):35S-37S. PubMed ID: 1767805 [TBL] [Abstract][Full Text] [Related]
3. Comparison of organ-specific toxicity of temafloxacin in animals and humans. Krasula RW; Pernet AG Am J Med; 1991 Dec; 91(6A):38S-41S. PubMed ID: 1662894 [TBL] [Abstract][Full Text] [Related]
4. Side-effects of quinolones: comparisons between quinolones and other antibiotics. Norrby SR Eur J Clin Microbiol Infect Dis; 1991 Apr; 10(4):378-83. PubMed ID: 1864300 [TBL] [Abstract][Full Text] [Related]
5. Central nervous system toxicity of quinolones: human and animal findings. Christ W J Antimicrob Chemother; 1990 Oct; 26 Suppl B():219-25. PubMed ID: 2124211 [TBL] [Abstract][Full Text] [Related]
6. A comparative study of the repeat dose toxicity of grepafloxacin and a number of other fluoroquinolones in rats. Takizawa T; Hasimoto K; Itoh N; Yamashita S; Owen K Hum Exp Toxicol; 1999 Jan; 18(1):38-45. PubMed ID: 10025367 [TBL] [Abstract][Full Text] [Related]
7. [Cartilage-damaging effect of quinolones]. Stahlmann R Infection; 1991; 19 Suppl 1():S38-46. PubMed ID: 2007514 [TBL] [Abstract][Full Text] [Related]
8. Adverse reactions and interactions of fluoroquinolones. Ball P Clin Invest Med; 1989 Feb; 12(1):28-34. PubMed ID: 2646053 [TBL] [Abstract][Full Text] [Related]
10. Clinical toxicological aspects of fluoroquinolones. Stahlmann R Toxicol Lett; 2002 Feb; 127(1-3):269-77. PubMed ID: 12052667 [TBL] [Abstract][Full Text] [Related]
11. [The history of the development and changes of quinolone antibacterial agents]. Takahashi H; Hayakawa I; Akimoto T Yakushigaku Zasshi; 2003; 38(2):161-79. PubMed ID: 15143768 [TBL] [Abstract][Full Text] [Related]
13. Clinical features and management of adverse effects of quinolone antibacterials. Paton JH; Reeves DS Drug Saf; 1991; 6(1):8-27. PubMed ID: 2029356 [TBL] [Abstract][Full Text] [Related]
14. Toxicity of quinolones. Stahlmann R; Lode H Drugs; 1999; 58 Suppl 2():37-42. PubMed ID: 10553703 [TBL] [Abstract][Full Text] [Related]
15. Fluoroquinolones in children: poorly defined risk of joint damage. Prescrire Int; 2004 Oct; 13(73):184-6. PubMed ID: 15499700 [TBL] [Abstract][Full Text] [Related]
16. Drug interactions with quinolone antibacterials. Brouwers JR Drug Saf; 1992; 7(4):268-81. PubMed ID: 1524699 [TBL] [Abstract][Full Text] [Related]
17. Quinolones in children. Are concerns over arthropathy justified? Stahlmann R; Förster C; Van Sickle D Drug Saf; 1993 Dec; 9(6):397-403. PubMed ID: 8129861 [No Abstract] [Full Text] [Related]
18. Toxicity of quinolone antimicrobial agents. Takayama S; Hirohashi M; Kato M; Shimada H J Toxicol Environ Health; 1995 May; 45(1):1-45. PubMed ID: 7752287 [TBL] [Abstract][Full Text] [Related]
19. Safety profile of the quinolones. Stahlmann R J Antimicrob Chemother; 1990 Nov; 26 Suppl D():31-44. PubMed ID: 2286589 [TBL] [Abstract][Full Text] [Related]
20. New quinolones: in vitro effects as a potential source of clinical toxicity. Forsgren A; Bredberg A; Riesbeck K Rev Infect Dis; 1989; 11 Suppl 5():S1382-9. PubMed ID: 2549607 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]